Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.
Source: insidermonkey.com
Stay updated with breaking news from Joining Alex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.
Operator: Good morning and welcome to Fulcrum Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Brian Moos / KVSC Program Director / @brian_moos The Huskies have moved onto the West Regional Final in the NCAA Tournament. Riding the hot hand of Jaxon Cas